Medtronic MiniMed 780G Insulin Pump Recall Over Delivery Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medtronic MiniMed, Inc. is recalling 453,144 units of the MiniMed 780G Insulin Pump due to potential unintended over- or under-delivery of insulin caused by gravitational forces, which could lead to serious health risks.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references Worldwide, including United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medtronic MiniMed, Inc. is recalling the MiniMed 780G Insulin Pump because it may cause unintended over-delivery or under-delivery of insulin due to changes in gravitational force affecting pressures, potentially resulting in severe hypoglycemia, seizure, coma, death, severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Which Products Are Affected
The affected products are the MiniMed 780G Insulin Pump with model numbers MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, and MMT-1896. The recall involves 453,144 units distributed worldwide, including US nationwide across states such as OR, CA, AZ, NY, TX, FL, OH, MO, TN, NJ, NC, SC, IL, VA, WA, DC, GA, PA, MS, IA, MI, NH, OK, SD, MT, WI, WV, MA, LA, MN, RI, AR, ME, AL, IN, UT, KY, CO, ND, MD, CT, NM, KS, ID, NV, DE, NE, VT, AK, HI, WY, PR, VI, and countries including Taiwan, Canada, and others. The official recall number is Z-1741-2026, with various UDI-DI codes listed in the recall notice.
What You Should Do
Consumers who have the affected MiniMed 780G Insulin Pumps should follow the initial firm notification, which was issued via letter, and contact Medtronic MiniMed, Inc. at their address: 18000 Devonshire St, Northridge, CA 91325-1219, for further instructions on returns or refunds.
Why This Matters
This recall affects a large number of insulin pumps essential for diabetes management, potentially leading to life-threatening conditions if not addressed, highlighting the importance of device safety in medical technology.
Source
According to the FDA recall notice with number Z-1741-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,611 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.